Napp nabs Dietmar Leitner as MD
This article was originally published in Scrip
Napp Pharmaceuticals, a company developing drugs for pain control, cancer and respiratory illnesses, has appointed Dietmar Leitner managing director. Mr Leitner joins Napp from Mundipharma Gesellschaft, where he was managing director. He succeeds Antony Mattessich who left the company in May 2011 to become regional director of Europe at Mundipharma International.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.